Production (Stage)
Passage Bio, Inc.
PASG
$0.4228
-$0.0272-6.04%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -15.46% | -17.48% | -13.71% | -17.34% | -23.94% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -28.45% | -28.93% | -27.31% | -21.83% | -24.34% |
| Operating Income | 28.45% | 28.93% | 27.31% | 21.83% | 24.34% |
| Income Before Tax | 24.84% | 36.54% | 38.78% | 31.61% | 33.86% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 24.84% | 36.54% | 38.78% | 31.61% | 33.86% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 24.84% | 36.54% | 38.78% | 31.61% | 33.86% |
| EBIT | 28.45% | 28.93% | 27.31% | 21.83% | 24.34% |
| EBITDA | 28.37% | 29.43% | 27.71% | 22.22% | 24.98% |
| EPS Basic | 33.09% | 42.38% | 42.87% | 33.88% | 34.53% |
| Normalized Basic EPS | 37.34% | 36.52% | 33.50% | 26.64% | 28.09% |
| EPS Diluted | 33.09% | 42.42% | 42.91% | 33.92% | 34.57% |
| Normalized Diluted EPS | 37.34% | 36.52% | 33.50% | 26.64% | 28.09% |
| Average Basic Shares Outstanding | 12.13% | 10.33% | 7.29% | 4.26% | 1.19% |
| Average Diluted Shares Outstanding | 12.13% | 10.33% | 7.29% | 4.26% | 1.19% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |